Nuveen LLC significantly reduced its stake in Philip Morris International Inc. (NYSE:PM) by 1.2% in the fourth quarter, selling 119,007 shares. Despite this, Nuveen LLC still holds a substantial 0.64% of the company's stock, valued at over $1.5 billion. Several other institutional investors also modified their holdings in PM, and analysts generally maintain a "Buy" rating with an average price target of $192.88.

Meiji Yasuda America Inc has acquired a new stake worth approximately $6.97 million in Philip Morris International Inc. during the fourth quarter, representing 1.6% of its holdings. This comes as Philip Morris International reported stronger-than-expected quarterly results with an EPS of $1.96 and revenue of $10.15 billion, also declaring a quarterly dividend of $1.47 per share. Analysts maintain a "Moderate Buy" rating with an average target price of $192.88.

Zacks Research downgraded lululemon athletica (NASDAQ:LULU) from "hold" to "strong sell," reflecting cautious analyst sentiment. Several other firms also reduced price targets, leading to a consensus "Reduce" rating and an average target price of $154.26. Despite this, lululemon reported Q1 earnings and revenue that surpassed expectations, though the stock is trading near its 52-week low.

Heinz and Heineken have officially launched their first collaboration: a limited-edition Heinz x Heineken six-pack, containing five Heineken beers and one bottle of Heinz Tomato Ketchup. This partnership, which has been 150 years in the making, also includes a limited edition jersey. Fans can win the exclusive six-pack and jersey via the Heinz Instagram, celebrating an "unexpected but obvious" pairing that both brands believe brings people together.

UniSuper Management Pty Ltd reduced its stake in Thermo Fisher Scientific Inc. by 3.7%, selling 5,100 shares and retaining 132,840 shares valued at $76.97 million. Despite UniSuper's sale, institutional interest in Thermo Fisher remains strong, with 89.23% of the stock owned by institutions, and the company recently reported better-than-expected Q1 results and positive FY 2026 EPS guidance. Analysts generally have a "Moderate Buy" rating with a consensus target price of $608.95.

Nuveen LLC significantly increased its stake in Thermo Fisher Scientific, purchasing an additional 846,111 shares in the fourth quarter, bringing its total holdings to 2.15 million shares valued at approximately $1.24 billion. The company reported strong financial results, surpassing analyst expectations for both earnings per share and revenue, and declared a quarterly dividend of $0.47 per share. Analysts maintain a "Moderate Buy" rating for Thermo Fisher Scientific, with an average target price of $608.95.

Meiji Yasuda America Inc has invested $1.91 million in Vertex Pharmaceuticals by acquiring 4,216 shares in the fourth quarter. This comes as Vertex's CASGEVY therapy shows promise and the company pursues additional global regulatory submissions. Despite some insider selling, analysts maintain a "Moderate Buy" rating for VRTX, which recently surpassed quarterly EPS estimates.

Meiji Yasuda America Inc has made a new investment in Boston Scientific Corporation, purchasing 49,376 shares worth approximately $4.7 million in the fourth quarter. Despite the stock being under pressure due to a guidance cut and slower growth concerns, institutional investors continue to hold a significant stake, and analysts largely remain positive, supported by a recent $5 billion share buyback authorization. Several other hedge funds have also modified their positions in Boston Scientific, reflecting ongoing institutional interest.

Qtron Investments LLC significantly increased its stake in Netflix, Inc. (NASDAQ:NFLX) by 819.1% in the fourth quarter, now owning 49,919 shares valued at $4.68 million. This move is part of a broader trend of hedge funds and institutional investors boosting their positions in Netflix, with such entities now holding 80.93% of the stock. Despite some analysts trimming price targets due to a lack of immediate catalysts, Wall Street maintains a "Moderate Buy" consensus rating for Netflix with an average price target of $114.39.

Parnassus Investments LLC decreased its stake in Cummins Inc. (NYSE:CMI) by 3.9% in the fourth quarter, selling 11,487 shares and leaving them with 280,004 shares valued at $142.9 million. This transaction comes amidst other institutional investors also adjusting their holdings in Cummins. Analysts have set a "Moderate Buy" consensus rating for CMI with a target price of $726.14, and the company recently announced a quarterly dividend of $2.00 per share.